Novartis has announced an intention to separate the Sandoz business to create a standalone company by way of a 100% spin-off.
Updates
August 25, 2022
LinkedIn article from Richard Saynor on proposed spin-off
Meet Novartis Management
September 22, 2022
Read the media release
Watch a replay of the webcast
Media Release
August 25, 2022
English | German
Investors
August 25, 2022
Watch the webcast
Download the presentation (PDF 1.1 MB)